Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: Open-label pilot study-Reference-Cited by-同舟云学术

Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: Open-label pilot study

Published:2008-09 Issue:6 Volume:12 Page:650-655
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:

Author:

Zhu Jun Hui,Wang Xing Xiang,Zhang Fu Rong,Shang Yun Peng,Tao Qian Min,Zhu Jian Hua,Chen Jun Zhu

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-3046.2007.00863.x/fullpdf

Reference38 articles.

1. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry;D’Alonzo;Ann Intern Med,1991

2. Idiopathic pulmonary arterial hypertension in children;Rosenzweig;Curr Opin Pediatr,2005

3. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension;Rich;N Engl J Med,1992

4. Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin);Higenbottam;Lancet,1984

5. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin;Barst;Ann Intern Med,1994

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRASCET—Transamniotic Stem Cell Therapy;Current Stem Cell Reports;2024-04-19

2. Stem cell therapy in pulmonary hypertension: current practice and future opportunities;European Respiratory Review;2023-09-27

3. The Future of Heart and Lung Transplantation;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08

4. Endothelial progenitor cell-derived exosomes inhibit pulmonary artery smooth muscle cell in vitro proliferation and resistance to apoptosis by modulating the Mitofusin-2 and Ras-Raf-ERK1/2 signaling pathway;European Journal of Pharmacology;2023-06

5. Transamniotic stem cell therapy (TRASCET): An emerging minimally invasive strategy for intrauterine stem cell delivery;Seminars in Perinatology;2023-04